Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 3,390.00
+90.00 (2.73%)
Oct 31, 2025, 5:00 PM SAST
Dis-Chem Pharmacies Income Statement
Financials in millions ZAR. Fiscal year is March - February.
Millions ZAR. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2016 - 2020 |
| 40,884 | 39,172 | 36,283 | 32,664 | 30,407 | 26,278 | Upgrade | |
Revenue Growth (YoY) | 7.62% | 7.96% | 11.08% | 7.42% | 15.71% | 9.56% | Upgrade |
Cost of Revenue | 31,726 | 30,372 | 28,067 | 25,076 | 23,576 | 20,442 | Upgrade |
Gross Profit | 9,158 | 8,800 | 8,217 | 7,587 | 6,830 | 5,836 | Upgrade |
Selling, General & Admin | 1,307 | 1,307 | 1,212 | 984.49 | 803.97 | 4,964 | Upgrade |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 55.96 | Upgrade |
Other Operating Expenses | 5,624 | 5,359 | 5,201 | 4,837 | 4,467 | -1,173 | Upgrade |
Operating Expenses | 6,961 | 6,696 | 6,437 | 5,843 | 5,291 | 4,495 | Upgrade |
Operating Income | 2,197 | 2,104 | 1,779 | 1,744 | 1,539 | 1,341 | Upgrade |
Interest Expense | -540.33 | -521.01 | -466.23 | -370.45 | -324.85 | -344.58 | Upgrade |
Interest & Investment Income | 30.4 | 30.4 | 26.3 | 20.21 | 12.1 | 16.44 | Upgrade |
Earnings From Equity Investments | 21.79 | 20.21 | 45.27 | 22.78 | 1.19 | 3 | Upgrade |
Other Non Operating Income (Expenses) | 11.67 | - | - | - | -0.63 | -75.65 | Upgrade |
EBT Excluding Unusual Items | 1,721 | 1,634 | 1,385 | 1,417 | 1,227 | 940.49 | Upgrade |
Other Unusual Items | - | - | - | - | - | 0.46 | Upgrade |
Pretax Income | 1,721 | 1,634 | 1,385 | 1,417 | 1,227 | 940.94 | Upgrade |
Income Tax Expense | 439.18 | 414.46 | 364.09 | 389.18 | 337.12 | 253.29 | Upgrade |
Earnings From Continuing Operations | 1,281 | 1,219 | 1,020 | 1,028 | 890.1 | 687.65 | Upgrade |
Minority Interest in Earnings | -46.23 | -39.43 | -36.01 | -27.32 | -36.66 | -18.96 | Upgrade |
Net Income | 1,235 | 1,180 | 984.48 | 1,000 | 853.45 | 668.69 | Upgrade |
Net Income to Common | 1,235 | 1,180 | 984.48 | 1,000 | 853.45 | 668.69 | Upgrade |
Net Income Growth | 16.39% | 19.84% | -1.57% | 17.20% | 27.63% | 11.78% | Upgrade |
Shares Outstanding (Basic) | 857 | 857 | 858 | 860 | 860 | 860 | Upgrade |
Shares Outstanding (Diluted) | 858 | 858 | 858 | 860 | 860 | 860 | Upgrade |
Shares Change (YoY) | 0.05% | -0.01% | -0.26% | -0.01% | 0.08% | 0.00% | Upgrade |
EPS (Basic) | 1.44 | 1.38 | 1.15 | 1.16 | 0.99 | 0.78 | Upgrade |
EPS (Diluted) | 1.44 | 1.38 | 1.15 | 1.16 | 0.99 | 0.78 | Upgrade |
EPS Growth | 16.33% | 19.88% | -1.38% | 17.24% | 27.55% | 11.78% | Upgrade |
Free Cash Flow | 492.7 | -25.46 | 863.11 | 230 | 1,459 | 762.39 | Upgrade |
Free Cash Flow Per Share | 0.57 | -0.03 | 1.01 | 0.27 | 1.70 | 0.89 | Upgrade |
Dividend Per Share | 0.548 | 0.548 | 0.457 | 0.466 | 0.397 | 0.311 | Upgrade |
Dividend Growth | 143.78% | 19.89% | -1.79% | 17.34% | 27.61% | 143.11% | Upgrade |
Gross Margin | 22.40% | 22.47% | 22.64% | 23.23% | 22.46% | 22.21% | Upgrade |
Operating Margin | 5.37% | 5.37% | 4.90% | 5.34% | 5.06% | 5.10% | Upgrade |
Profit Margin | 3.02% | 3.01% | 2.71% | 3.06% | 2.81% | 2.54% | Upgrade |
Free Cash Flow Margin | 1.21% | -0.07% | 2.38% | 0.70% | 4.80% | 2.90% | Upgrade |
EBITDA | 2,288 | 2,535 | 2,165 | 2,079 | 1,790 | 1,580 | Upgrade |
EBITDA Margin | 5.60% | 6.47% | 5.97% | 6.36% | 5.89% | 6.01% | Upgrade |
D&A For EBITDA | 90.81 | 431.38 | 386.14 | 334.64 | 250.5 | 239.03 | Upgrade |
EBIT | 2,197 | 2,104 | 1,779 | 1,744 | 1,539 | 1,341 | Upgrade |
EBIT Margin | 5.37% | 5.37% | 4.90% | 5.34% | 5.06% | 5.10% | Upgrade |
Effective Tax Rate | 25.52% | 25.37% | 26.30% | 27.47% | 27.47% | 26.92% | Upgrade |
Advertising Expenses | - | 632.6 | 637.81 | 521.39 | 394.22 | 319.03 | Upgrade |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.